Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$0.29 - $0.47 $174 - $282
-600 Reduced 5.31%
10,700 $0
Q3 2022

Oct 25, 2022

BUY
$0.38 - $0.73 $228 - $438
600 Added 5.61%
11,300 $0
Q1 2022

Apr 14, 2022

SELL
$0.53 - $1.19 $15,158 - $34,034
-28,600 Reduced 72.77%
10,700 $0
Q4 2021

Jan 18, 2022

SELL
$1.03 - $2.31 $16,480 - $36,960
-16,000 Reduced 28.93%
39,300 $2,000
Q3 2021

Oct 26, 2021

SELL
$1.74 - $2.93 $210,888 - $355,116
-121,200 Reduced 68.67%
55,300 $19,000
Q2 2021

Jul 19, 2021

SELL
$1.52 - $3.62 $54,720 - $130,320
-36,000 Reduced 16.94%
176,500 $275,000
Q1 2021

Apr 26, 2021

BUY
$0.9 - $6.32 $191,250 - $1.34 Million
212,500 New
212,500 $316,000

Others Institutions Holding ASXC

About ASENSUS SURGICAL, INC.


  • Ticker ASXC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 236,719,008
  • Market Cap $82.9M
  • Description
  • Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...
More about ASXC
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.